Safety and Efficacy of a Novel Sealant‐Based Vascular Closure Device Following Electrophysiology Procedures: ReliaSeal Trial
The use of VCD resulted in significant reductions in TTA, TTH, and TTDE, with no major or minor complications and a high success rate.
Authors
- Andrew Brenyo
- Robert Beasley (ORCID: https://orcid.org/0000-0002-4635-3392)
- Sanjaya Gupta (ORCID: https://orcid.org/0000-0002-1789-4712)
- Vijay Swarup
- Ian Parker
- Layth Saleh
- J.R. Pérez Sánchez (ORCID: https://orcid.org/0000-0001-9292-9471)
- John Summers
- Joseph M. Bumgarner
- Sadanandan
Institutions
- Medical City Dallas Hospital (US)
- Arizona Heart Hospital (US)
- St. Joseph's Hospital (US)
- Oklahoma Heart Hospital (US)
- University of Fort Lauderdale (US)
- Clinical Solutions (US)
- St. Anthony’s Hospital (US)
- St. Anthony Hospital (US)
- Saint Luke's Hospital (US)
- Rhythm (United states) (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1111/jce.16623
- Citations
- 2
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 5.03
Funders
- Cordis